DOCSLIB.ORG

View Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
View Program GENERAL INFORMATION FOR THE 2016 CANADIAN DIGESTIVE DISEASES WEEK™ (CDDW™) SCIENTIFIC SESSIONS: Centre Ice Gala – Sunday February 28 The Gastroenterology Residents in Training (GRIT) Program (by Pull on your favourite hockey jersey, and enjoy the company of fellow invitation only) will be held at the Fairmont Queen Elizabeth. hockey fans as CDDW™ hosts the “Centre Ice Gala”. Treat your taste Registration Desk Hours – Foyer, Conference Level buds to the most exotic stadium cuisine, test out your stick handling Tuesday, February 23 12h00-21h30 skills, and skate the night away with tunes from our own Power Play DJ. Wednesday, February 24 08h00-20h30 Purchase tickets ($100 + tax) online and also at registration on-site. Thursday, February 25 07h00-17h00 CanMEDS ROLES The Scholars’ and Research Topics in Gastrointestinal (GI) Disease CanMEDS is a framework that identifies and describes the abilities Programs (invitation only) will be held at the Fairmont Queen Elizabeth. physicians require to effectively meet the health care needs of the people they serve. These abilities are grouped thematically under seven Registration Desk Hours – Foyer, Conference Level roles: Medical Expert (the integrating role), Communicator, Collaborator, Wednesday, February 24 08h00-20h30 Leader, Health Advocate, Scholar and Professional. The CDDW™ Thursday, February 25 07h00-17h00 program will include CanMEDS roles which will be identified at the All core sessions of CDDW™ will be held at the Fairmont Queen beginning of each session. For more information on these newly revised Elizabeth. Registration Desk hours – Mezzanine Level definitions, visit: Thursday, February 25 17h00-21h00 http://www.royalcollege.ca/portal/page/portal/rc/canmeds/framework. Friday, February 26 07h00-18h30 Saturday, February 27 07h00-18h30 ACCREDITATION Sunday, February 28 07h30-18h30 The CDDW™ Meeting is accredited as a group learning activity (Section Monday, February 29 07h30-14h00 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada (RCPSC) (as the EXHIBIT HOURS conference overall includes at least 25% interactive time). See page 35 The Exhibit and Trade Show will be held in the Le Grand for a listing of credits per session. Financial support for sessions, as Salon/Hochelagas 1-3 and will be open as follows: indicated within the program, is through educational grants. CDDW™ is Friday, February 26 09h30-18h30 in compliance with the CQDPCM (Quebec) Code of Ethics. For more Saturday, February 27 10h30-15h30 information, please go to: http://www.cemcq.qc.ca/en/index_guide.cfm. Sunday, February 28 10h30-15h30 Live educational activities, occurring in Canada, recognized by the RCPSC as Accredited Group Learning Activities (Section 1) are deemed SPEAKER READY ROOM by the European Union of Medical Specialists eligible for ECMEC Please note that all speakers are asked to present themselves at the credits. Speaker Ready Room, Saint Charles, at least two hours before their presentation. Through an agreement between the RCPSC and the American Medical Speaker Ready Room Hours Association, physicians may convert RCPSC MOC credits to AMA PRA Thursday, February 25 17h00-21h00 Category 1 Credits™. Information on the process to convert RCPSC Friday-Sunday, February 26-28 07h00-18h00 MOC credit to AMA credit can be found at Monday, February 29 07h00-14h00 http://www.amaassn.org/go/internationalcme NO presentation preparation/loading for plenary sessions will be The 2016 CDDW™ is endorsed by: permitted to take place in rooms Marquette/Jolliett, Duluth or the Faculty who are American College of Mackenzie. Breakfast and small group presentations may be loaded Gastroenterology Fellows or Masters are identified in those rooms. throughout the program by the * symbol CDDW™ IMPLEMENTATION COMMITTEE Co-Chairs David Armstrong, CAG President Elect Richard Schreiber, CASL President Elect CAG Committee CASL Committee Derek McKay, Past Co-Chair Eberhard Renner, Past Co-Chair Kevin Waschke, Education Hemant Shah, Education François Boudreau, Research Christopher Rose, Research Wallace MacNaughton, Finance Kelly Burak, Finance Paul Sinclair, Executive Director GRIT Course Scholars’ Program Mark Borgaonkar, Geoff Williams Herbert Brill, Saumya Jayakumar Research Topics in GI Disease Gilaad Kaplan, Elena Verdu 1 CDDW™– PROGRAM AT A GLANCE Start FRIDAY February 26 SATURDAY February 27 SUNDAY February 28 MONDAY February 29 Start 07h00▲ 07h00▲ CAG Open Mic 07h30▲ 07h30▲ 08h00▲ Difficult Celiac Barrett's HRS and Difficult H pylori Difficult Cases in Ulcerative 08h00▲ 08h30▲ IBD Community-based GI and AILD Cases Disease Esophagus SBP Cases in CD Therapeutics Colitis 08h30▲ Microbiota Liver Disease Epigenetics 09h00▲ of GI Cancer CASL Paper Innate 09h00▲ Precision Medicine in Luminal Signaling to 2015 Papers Session 1 Mucosal CASL Paper The Future of 09h30▲ Exhibits & Coffee Break Gastroenterology Nerves in Functional Influencing 09h30▲ Immunology Session 2 Hepatology 10h00▲ Disorders Practice 10h00▲ CAG/CCC CASL-CLF Gold Medal Lecture Clinical Inpatient 10h30▲ Student Exhibits & Coffee Break Exhibits & Coffee Break Coffee Break 10h30▲ papers Hepatology 11h00▲ Prizes 11h00▲ Small Group Sessions Small Group Sessions Small Groups 11h30▲ 11h30▲ Exhibits & Lunch (11h30-12h30) 12h00▲ Small Group Sessions Small Group Sessions Small Groups 12h00▲ 12h30▲ 12h30▲ Exhibits & Lunch (12h30-13h30) Exhibits & Lunch (12h30-13h30) Lunch (12h30-13h30) 13h00▲ Cellular 13h00▲ Reprogram Safety Monitoring 13h30▲ 13h30▲ ming Research Research Hepato- Updates in Pediatric The Role of Nutrition in Rapid Fire 2015 Journal Therapeutics in IBD: Past, 14h00▲ Career Aw ard cellular 14h00▲ Cholestasis Gastroenterology Review present and future 14h30▲ Exhibits & Coffee Break Development Lectures Carcinoma 14h30▲ 15h00▲ Exhibits & Coffee Break Exhibits & Coffee Break 15h00▲ Colonic 15h30▲ Video Endoscopy Kopelman 15h30▲ Motility Optimizing Fatty Liver Monitoring Disease New HCV 16h00▲ Lecture Diarrhea and Constipation 16h00▲ Outcomes Activity in IBD Technologies Update 16h30▲ 16h30▲ CASL AGM CAG AGM 17h00▲ McKenna Reception 17h00▲ Aw ards Ceremony 17h30▲ 17h30▲ CDDW™ Opening Reception McKenna Lecture 18h00▲ 18h00▲ 18h30▲ Poster Session 2 18h30▲ 19h00▲ Trainee Mixer Poster Session 1 19h00▲ 19h30▲ 19h30▲ 20h00▲ 20h00▲ Gala Evening AGM annual general meeting; AILD autoimmune liver disease; CCC Crohn’s and Colitis Canada; CD Crohn’s disease; CLF Canadian Liver Foundation; GI gastrointestinal; H pylori Helicobacter pylori; HCV hepatitis C virus; HRS hepatorenal syndrome; IBD inflammatory bowel disease; SBP spontaneous bacterial peritonitis 2 FRIDAY FEBRUARY 26 OVERALL LEARNING OBJECTIVE FOR CDDW™ 2016 At the end of the conference delegates will be able to: 1. Identify evolving new areas of clinical and basic research in gastroenterology and hepatology. 2. Affirm through evaluation of the evidence that knowledge and management strategies are current. 3. Formulate management strategies for patients with gastrointestinal, including liver, disease. 4. Compare and contrast a wide variety of therapeutic approaches in the care of patients with gastrointestinal, including liver, diseases. 5. Recognize the importance of quality measures and patient safety initiatives in clinical and endoscopic practice. 6. Interact with colleagues to foster a community of practice. CAG/CASL POSTGRADUATE COURSE Specialists may be defined by their knowledge of the leading edge issues in gastroenterology and hepatology. The Postgraduate Course is intended to bring you up to date on developments in selected areas and get you ready for the challenges of 2016. 08h00-09h30 CAG/CASL POSTGRADUATE COURSE: Marquette/Jolliet Community-based Gastrointestinal and Liver Disease Learning Objectives: At the end of this session participants will be able to: 1. Review the selection of biologic agents to treat IBD and understand the role of combination therapy. 2. Discuss the time interval of endoscopic surveillance for: IBD-associated neoplasia, colonic polyps, and Barrett’s esophagus. 3. Describe the staging of hepatitis C disease, and explore the role of community gastroenterologists in accessing and implementing new treatments. Co-Chairs: Geoffrey Nguyen, University of Toronto and Kevork Peltekian, Dalhousie University Mirror, Mirror on the Wall, Which Biologic Combo Will Fare Best of All? Brian Bressler, University of British Columbia Timing is Everything: How often should we perform endoscopic surveillance? Marietta Iacucci, University of Calgary Charging the Frontlines: Real world challenges with the new hepatitis C therapy Hemant Shah, University of Toronto – CAG co-developed this program with Bristol-Myers Squibb Canada to achieve scientific integrity, objectivity and balance – 08h00-09h30 †CAG SYMPOSIUM: Mackenzie IBD Microbiota Learning Objectives: At the end of this session participants will be able to: 1. Understand the complexity of dietary-microbiota interactions and the role they play in modulation of intestinal inflammation. 2. Discuss the role of bacterial anti-fungal dysbiosis in IBD. 3. Review the current therapies and levels of evidence regarding therapies targeting the microbiome in IBD. Co-Chairs: Michael Surette, McMaster University and Elena Verdu, McMaster University Diet-Microbiota Interactions in IBD: From basics to clinics Karen Madsen, University of Alberta Beyond Bacterial Dysbiosis: Fungal signature in IBD Frederic Bushman, University of Pennsylvania Microbiota Directed Therapies for IBD: Focus
Load more

Recommended publications
  • Adherence to Surveillance Guidelines Following Colonic Polypectomy Is Abysmal
    170 Original Article Adherence to surveillance guidelines following colonic polypectomy is abysmal Frederick H. Koh1, Dedrick K. H. Chan1,2, Jingyu Ng3, Ker-Kan Tan1,2 1Division of Colorectal Surgery, University Surgical Cluster, National University Hospital, National University Health Systems, Singapore, Singapore; 2Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 3Division of Colorectal Surgery, Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore Contributions: (I) Conception and design: FH Koh, KK Tan; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: FH Koh, DK Chan, J Ng; (V) Data analysis and interpretation: FH Koh, DK Chan, J Ng; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Ker-Kan Tan. Division of Colorectal Surgery, University Surgical Cluster, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore. Email: [email protected]. Background: Surveillance guidelines following excision of colonic tubular adenomas are well established. However, adherence to the guidelines are rarely audited. The aim of our study was to evaluate the rate of compliance to the recommended guidelines following polyp removal. Methods: A review of a prospectively collected colonoscopy database in a single tertiary institution was conducted for all patients who underwent polypectomy in 2008. We excluded patients who were diagnosed with or had prior history of colorectal malignancy. The frequency of subsequent colonoscopic were evaluated against the recommended guidelines based on the clinico-histological characteristics of the removed polyps. Results: There were 419 colonoscopies with polypectomies performed in 2008.
    [Show full text]
  • Issues in the Diagnosis and Management of Functional
    By BSc (Hons), Grad Dip Sc. Comm., Grad Dip Psych A thesis submitted for the degree of School of Medicine Faculty of Health Sciences June 2017 1 TABLE OF CONTENTS TABLE OF CONTENTS .............................................................................................................................2 LIST OF FIGURES AND TABLES ...................................................................................................................6 ABSTRACT ...........................................................................................................................................8 DECLARATION..................................................................................................................................... 10 ACKNOWLEDGEMENTS ........................................................................................................................... 11 CONFERENCE PRESENTATIONS ................................................................................................................. 12 ADDITIONAL PUBLICATIONS ARISING FROM THE PHD RESEARCH .......................................................................... 13 CHAPTER 1 : OVERVIEW ..................................................................................................... 14 References .................................................................................................................................. 17 CHAPTER 2 : INTRODUCTION .............................................................................................. 18
    [Show full text]
  • Laparoscopic Colorectal Surgery for Colorectal Polyps: Experience of Ten Years
    ACTA MEDICA LITUANICA. 2017. Vol. 24. No. 1. P. 18–24 © Lietuvos mokslų akademija, 2017 Laparoscopic colorectal surgery for colorectal polyps: experience of ten years Audrius Dulskas1, Background. Laparoscopy or its combination with endoscopy is the next step for “difficult” polyps. The purpose of the paper was to Žygimantas Kuliešius1, review the outcomes of the laparoscopic approach to the management of “difficult” colorectal polyps. Narimantas E. Samalavičius1, 2 Materials and methods. From 2006 to 2016, 58 patients who under- went laparoscopic treatment for “difficult” polyps that could not be treat- 1 Department of Abdominal and ed by endoscopy at the National Cancer Institute, Lithuania, were includ- General Surgery and Oncology, ed. The demographic data, the type of surgery, length of post-operative National Cancer Institute, stay, complications, and final pathology were reviewed prospectively. Vilnius, Lithuania Results. The mean patient was 65.9 ± 8.9 years of age. Laparoscop- ic mobilization of the colonic segment and colotomy with removal of 2 Clinic of Internal Diseases, Family Medicine and the polyp was performed in 15 (25.9%) patients, laparoscopic segmental Oncology, Faculty of Medicine, bowel resection in 41 (70.7%) cases: anterior rectal resection with par- Vilnius University tial total mesorectal excision in 18 (31.0%), sigmoid resection in nine Vilnius, Lithuania (15.5%), left hemicolectomy in seven (12.1%), right hemicolectomies in two (3.4%), ileocecal resection in two (3.4%), resection of transverse colon in two (3.4%), and sigmoid resection with transanal retrieval of specimen in one (1.7%). Two patients (3.4%) underwent laparoscopic- assisted endoscopic polypectomy. The mean post-operative hospital stay was 5.7 ± 2.4 days.
    [Show full text]
  • ASGE Program and Abstracts
    Volume 85, No. 5S : DDW Abstract Issue : May 2017 ASGE Program and Abstracts www.giejournal.org ASGE members: www.asge.org ELSEVIER ISSN-0016-5107 YYMGE_v85_i5_sS_COVER.inddMGE_v85_i5_sS_COVER.indd 1 119-04-20179-04-2017 222:46:532:46:53 ASGE Program SATURDAY, MAY 6 ASGE PRESIDENTIAL PLENARY SESSION 8:34 AM 8:00 AM-10:30 AM Endoscopic or Surgical Step-Up Approach for Necrotizing Pancreatitis, A Multi-Center Randomized MCP: ROOM S100AB Controlled Trial Moderators: Kenneth R. McQuaid, MD, FASGE, John J. Sandra van Brunschot* Vargo II, MD, MPH, FASGE, Karen L. Woods, MD, FASGE 8:37 AM 8:00 AM JACK A. VENNES, MD AND STEPHEN E. SILVIS, MD PRESIDENTIAL WELCOME AND OVERVIEW ENDOWED LECTURE 8:03 AM Introduction: What Jack and Steve Meant to the Two Over-the-Scope-Clips Versus Standard Endoscopic of Us and to Endoscopy Therapy in Patients With Recurrent Peptic Ulcer John Baillie, MBChB, FASGE, Martin L. Freeman, MD, Bleeding – A Prospective Randomized, Multicenter FASGE Trial (STING) Endoscopy in the Management of Pancreatic Arthur Schmidt*, Stefan Goelder, Helmut Messmann, Necrosis: Standard of Care? Martin Goetz, Thomas Kratt, Alexander Meining, Michael Martin L. Freeman, MD, FASGE Birk, Stefan von Delius, Joerg Albert, Markus Escher, James Y. Lau, Arthur Hoffman, Reiner Wiest, Karel Caca 8:54 AM 8:06 AM Bilateral Versus Unilateral Deployment of a Metal Stent for a Non-Resectable Malignant High-Grade Endoscopic Treatment of Recurrent Peptic Ulcer Hilar Biliary Stricture: A Multicenter Prospective Bleeding Pitfalls, Promise, and Progress Randomized
    [Show full text]
  • Expert Opinions and Scientific Evidence for Colonoscopy Key
    Gut Online First, published on October 8, 2016 as 10.1136/gutjnl-2016-312043 Recent advances in clinical practice Expert opinions and scientific evidence for colonoscopy key performance indicators Gut: first published as 10.1136/gutjnl-2016-312043 on 8 October 2016. Downloaded from Colin J Rees,1 Roisin Bevan,2 Katharina Zimmermann-Fraedrich,3 Matthew D Rutter,2 Douglas Rex,4 Evelien Dekker,5 Thierry Ponchon,6 Michael Bretthauer,7 Jaroslaw Regula,8 Brian Saunders,9 Cesare Hassan,10 Michael J Bourke,11 Thomas Rösch3 ▸ Additional material is ABSTRACT While colonoscopy can detect CRC and prevent it published online only. To view Colonoscopy is a widely performed procedure with by removal of adenomas,12 it can also lead to please visit the journal online procedural volumes increasing annually throughout the serious complications and quality measures should (http://dx.doi.org/10.1136/ 13–16 gutjnl-2016-312043). world. Many procedures are now performed as part of ensure that these are minimised. Additionally, fi colorectal cancer screening programmes. Colonoscopy poor quality colonoscopy is associated with For numbered af liations see 17 18 end of article. should be of high quality and measures of this quality increased rates of interval cancers. A major should be evidence based. New UK key performance challenge is to deliver high quality colonoscopy in Correspondence to indicators and quality assurance standards have been the setting of ever-increasing demand and activity. Professor Colin J Rees, developed by a working group with consensus England has seen a 20% increase in colonoscopy Department of agreement on each standard reached.
    [Show full text]
  • A Minor but Deadly Surgery of Colonic Polypectomy in an Elderly And
    Yuan et al. World Journal of Surgical Oncology (2016) 14:252 DOI 10.1186/s12957-016-1010-6 CASE REPORT Open Access A minor but deadly surgery of colonic polypectomy in an elderly and fragile patient: a case report and the review of literature Xiaoming Yuan1†, Guangrong Zhou1†, Yan He2 and Aiwen Feng1* Abstract Background: Epithelial dysplasia and adenomatous polyps of colorectum are precancerous lesions. Surgical removal is still one of the important treatment approaches for colorectal polyps. Case presentation: A male patient over 78 years was admitted due to bloody stool and abdominal pain. Colonoscopic biopsy showed a high-grade epithelial dysplasia in an adenomatous polyp of sigmoid colon. Anemia, COPD, ischemic heart disease (IHD), arrhythmias, and hypoproteinemia were comorbidities. The preoperative preparation was carefully made consisting of oral nutritional supplements (ONS), blood transfusion, cardiorespiratory management, and hemostatic therapy. However, his illness did not improve but deteriorate mainly due to polyp rebleeding during preparative period. The open polypectomy was performed within 60 min under epidural anesthesia. Postoperative treatments included oxygen inhalation, bronchodilation, parenteral and enteral nutrition, human serum albumin, antibiotics, and blood transfusion. Unluckily, these did not significantly facilitate to surgical recovery on account of severe comorbidities and complications. The most serious complications were colonic leakage and secondary abdominal severe infection. The patient finally gave up treatment due to multiple organ dysfunction syndromes. Conclusions: The polypectomy for colonic polyp is a seemingly minor but potentially deadly surgery for patients with severe comorbidities, and prophylactic ostomy should be considered for the safety. Keywords: Colonic polyp, Hypoproteinemia, Anemia, COPD, Arrhythmias, Polypectomy, Intestinal leakage, Abdominal infection Background prophylactic ostomy is not explicitly elaborated in many Adenomatous polyp and epithelial dysplasia are regarded literatures [1–5].
    [Show full text]
  • British Society of Gastroe
    Guidelines Endoscopy in patients on antiplatelet or Gut: first published as 10.1136/gutjnl-2015-311110 on 12 February 2016. Downloaded from anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines Andrew M Veitch,1 Geoffroy Vanbiervliet,2 Anthony H Gershlick,3 Christian Boustiere,4 Trevor P Baglin,5 Lesley-Ann Smith,6 Franco Radaelli,7 Evelyn Knight,8 Ian M Gralnek,9,10 Cesare Hassan,11 Jean-Marc Dumonceau12 For numbered affiliations see ABSTRACT guidelines on the management of acute non- end of article. The risk of endoscopy in patients on antithrombotics variceal upper gastrointestinal bleeding.1 Correspondence to depends on the risks of procedural haemorrhage versus Recommendations for the management of Dr Andrew Veitch, Department thrombosis due to discontinuation of therapy. patients on antiplatelet therapy or anticoagulants of Gastroenterology, New P2Y12 receptor antagonists (clopidogrel, undergoing elective endoscopic procedures are out- Cross Hospital, Wolverhampton prasugrel, ticagrelor) For low-risk endoscopic lined in the algorithms in figures 1 and 2. Risk WV10 0QP, UK; procedures we recommend continuing P2Y12 receptor stratification for endoscopic procedures and anti- [email protected] antagonists as single or dual antiplatelet therapy (low platelet agents (APAs) are detailed in tables 1 and This article is published quality evidence, strong recommendation); For high-risk 2. There is no high-risk category of thrombosis for simultaneously in the journal endoscopic procedures in patients at low thrombotic risk, DOACs as they are not indicated for prosthetic Endoscopy. Copyright 2016 © we recommend discontinuing P2Y12 receptor metal heart valves. Warfarin risk stratification is Georg Thieme Verlag KG antagonists five days before the procedure (moderate detailed in table 3.
    [Show full text]
  • Endoscopic Removal of Colorectal Lesions—Recommendations by The
    US MULTI-SOCIETY TASK FORCE Endoscopic Removal of Colorectal LesionsdRecommendations by the US Multi-Society Task Force on Colorectal Cancer Tonya Kaltenbach,1 Joseph C. Anderson,2,3,4 Carol A. Burke,5 Jason A. Dominitz,6,7 Samir Gupta,8,9 David Lieberman,10 Douglas J. Robertson,2,3 Aasma Shaukat,11,12 Sapna Syngal,13 Douglas K. Rex14 This article is being published jointly in Gastrointestinal Endoscopy, Gastroenterology, and The American Journal of Gastroenterology. Colonoscopy with polypectomy reduces the incidence injection to lift the lesion before snare resection, have of and mortality from colorectal cancer (CRC).1,2 It is the evolved to improve complete and safer resection. The cornerstone of effective prevention.3 The National Polyp primary aim of polypectomy is the complete and safe Study showed that removal of adenomas during removal of the colorectal lesion and the ultimate preven- colonoscopy is associated with a reduction in CRC tion of CRC. This consensus statement provides recom- mortality by up to 50% relative to population controls.1,2 mendations to optimize complete and safe endoscopic The lifetime risk to develop CRC in the United States is removal techniques for colorectal lesions (Table 1), approximately 4.3%, with 90% of cases occurring after the based on available literature and experience. The age of 50 years.4 The recent reductions in CRC incidence recommendations from the US Multi-Society Task force and mortality have been largely attributed to the (USMSTF) on the management of malignant polyps, polyp- widespread uptake of CRC screening with polypectomy.5 osis syndromes,8 and surveillance after colonoscopy and The techniques and outcomes of polyp removal using polypectomy9 are available in other documents.
    [Show full text]
  • Safety and Efficacy of Hot Avulsion As an Adjunct to Endoscopic Mucosal Resection (With Videos)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by IUPUIScholarWorks ACCEPTED MANUSCRIPT Safety and efficacy of hot avulsion as an adjunct to endoscopic mucosal resection (with videos) Vinod Kumar MD1 Heather Broadley 2 Douglas K. Rex MD2 1Indiana University Health Methodist Hospital 2Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine Author contributions: Kumar: data retrieval, drafting of the manuscript, data and statistical analysis Broadley: data retrieval, critical review and approvalMANUSCRIPT of the manuscript Rex: study design, critical revision of the manuscript Conflicts of Interest: Dr. Rex is a consultant to Olympus America Corporation and Boston Scientific. None of the other authors identified a conflict of interest. Please send correspondence to: Douglas K. Rex University Hospital 550 North University Blvd Suite 4100 Indianapolis, IN ACCEPTED 46202 [email protected] This work was funded by a gift from Scott Schurz and his children to the Indiana Uni- versity Foundation, in the name of Douglas K Rex. ___________________________________________________________________ This is the author's manuscript of the article published in final edited form as: Kumar, V., Broadley, H., & Rex, D. K. (2018). Safety and efficacy of hot avulsion as an adjunct to endoscopic mucosal resection (with videos). Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2018.11.032 ACCEPTED MANUSCRIPT Abstract: Background: Excision of all visible neoplastic tissue is the goal of endoscopic mucosal resec- tion (EMR) of colorectal laterally spreading tumors (LSTs). Flat and fibrotic tissue can resist snaring. Ablation of visible polyps is associated with high recurrence rates. Avulsion is a technique to continue resection when snaring fails.
    [Show full text]
  • Download of These Slides, Please Direct Your Browser to the Following Web Address
    Clinical Roundtable Monograph Gastroenterology & Hepatology August 2018 Incomplete Resection Rates in Polyps Smaller Than 2 Centimeters Proceedings From a Live Clinical Roundtable Held During Digestive Disease Week • June 2-5, 2018 • Washington, DC Moderator David A. Johnson, MD Professor of Medicine Chief of Gastroenterology Eastern VA Medical School Norfolk, Virginia Discussants Michael B. Wallace, MD, MPH Professor of Medicine Mayo Clinic Jacksonville, Florida Vivek Kaul, MD, FACG, FASGE, AGAF Segal-Watson Professor of Medicine Chief, Division of Gastroenterology & Hepatology Center for Advanced Therapeutic Endoscopy University of Rochester Medical Center Rochester, New York Tonya Kaltenbach, MD, MS Associate Professor of Clinical Medicine University of California, San Francisco San Francisco, California Abstract: Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in the United States. Colonoscopy is the most effective strategy for preventing CRC. Although the benchmark of colonoscopy performance, the adenoma detection rate, clearly correlates with prevention of interval cancers and CRC-related death, it is clear that polyp (adenoma) detection is not enough. Adequate and complete resection of the adenoma is imperative to ensure effective CRC prevention. Polyp size is the primary risk factor for malignancy; in general, the bigger the polyp, the greater the risk for malignancy. This monograph, however, focuses on strategies to improve the incomplete resection rate for polyps smaller than 2 cm, as these represent the vast majority of polyps encountered in clinical practice. Selection of the polypectomy technique depends on the size and type of polyp. In general, cold forceps biopsy is used for polyps smaller than 4 mm, cold snare polypectomy is used for polyps 4 to 10 mm, and hot snare polypectomy and endoscopic mucosal resection (EMR) are highly effective for larger polyps.
    [Show full text]
  • Programma Najaarsvergadering 7 En 8 Oktober 2010
    Programma najaarsvergadering 7 en 8 oktober 2010 NEDERLANDSE VERENIGING VOOR GASTROENTEROLOGIE Sectie Gastrointestinale Endoscopie Netherlands Society for Parenteral and Enteral Nutrition Sectie Neurogastroenterologie en Motiliteit Sectie Experimentele Gastroenterologie Sectie Kinder-MDL Sectie Endoscopie Verpleegkundigen en Assistenten Vereniging Maag Darm Lever Verpleegkundigen NEDERLANDSE VERENIGING VOOR HEPATOLOGIE NEDERLANDSE VERENIGING VOOR GASTROINTESTINALE CHIRURGIE NEDERLANDSE VERENIGING VAN MAAG-DARM-LEVERARTSEN Locatie: NH KONINGSHOF VELDHOVEN INHOUDSOPGAVE pag Voorwoord 4 Belangrijke mededeling aan alle deelnemers aan de najaarsvergadering 5 Programma cursorisch onderwijs in mdl-ziekten 6 oktober 2010 6 Schematisch overzicht donderdag 7 oktober 2010 8 Schematisch overzicht vrijdag 8 oktober 2010 9 PROGRAMMA DONDERDAG 7 OKTOBER (aanvang 10.00 uur) IBD Symposium: “Optimale inzet van medicatie bij IBD” 10 Vrije voordrachten Nederlandse Vereniging voor Hepatologie 10 Vrije voordrachten Nederlandse Vereniging voor Gastrointestinale Chirurgie 13 Vrije voordrachten Nederlandse Vereniging voor Gastroenterologie 15 Symposium Sectie Neurogastroenterologie: “De dysmotore slokdarm” 15 Vrije voordrachten Nederlandse Vereniging voor Gastroenterologie 16 Tytgat Lecture 17 President Select sessie (plenair) 17 Uitreiking Janssen-Cilag Gastrointestinale Research-prijs 2010 18 Vrije voordrachten Nederlandse Vereniging voor Hepatologie 18 Symposium NVH: "Portale hypertensie en Leverfalen" 18 Vrije voordrachten Nederlandse Vereniging voor Hepatologie
    [Show full text]
  • Entrustable Professional Activities for General Surgery
    Entrustable Professional Activities for General Surgery 2020 VERSION 1.0 General Surgery: Foundations EPA #1 Assessing and providing initial management plans for patients presenting with a simple General Surgery problem Key Features: - This EPA includes conducting an appropriate history and physical examination, ordering and interpreting investigations, generating provisional and differential diagnoses, and developing and communicating a management plan for patients with simple surgical problems. Assessment Plan: Direct and indirect observation by surgeon, surgical fellow, or Core or TTP resident Use Form 1. Form collects information on: - Setting: inpatient; outpatient; emergency - Observation: direct; indirect Collect 5 observations of achievement - At least 1 direct observation - At least 2 different observers - At least 3 observations by faculty Relevant Milestones: 1 ME 1.5 Recognize urgent problems that may need the involvement of more experienced colleagues and seek their assistance 2 ME 2.2 Elicit an accurate, concise, and relevant history 3 ME 2.2 Perform a physical exam that informs the diagnosis 4 ME 2.2 Develop a differential diagnosis relevant to the patient’s presentation 5 ME 2.2 Select and/or interpret appropriate investigations, including imaging 6 ME 2.4 Develop and implement a plan for initial management © 2019 The Royal College of Physicians and Surgeons of Canada. All rights reserved. This document may be reproduced for educational purposes only provided that the following phrase is included in all related materials: Copyright © 2019 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission. Please forward a copy of the final product to the Office of Specialty Education, attn: Associate Director, Specialties.
    [Show full text]